PE20171140A1 - ANTI HYPERALGESIC, ANTIALODINIC AND ANT-INFLAMMATORY PHARMACOLOGICAL COMBINATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT, AND ITS USE FOR THE TREATMENT OF NEUROPATHIC PAIN - Google Patents

ANTI HYPERALGESIC, ANTIALODINIC AND ANT-INFLAMMATORY PHARMACOLOGICAL COMBINATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT, AND ITS USE FOR THE TREATMENT OF NEUROPATHIC PAIN

Info

Publication number
PE20171140A1
PE20171140A1 PE2017000033A PE2017000033A PE20171140A1 PE 20171140 A1 PE20171140 A1 PE 20171140A1 PE 2017000033 A PE2017000033 A PE 2017000033A PE 2017000033 A PE2017000033 A PE 2017000033A PE 20171140 A1 PE20171140 A1 PE 20171140A1
Authority
PE
Peru
Prior art keywords
treatment
neuropathic pain
pharmaceutical compositions
antialodinic
ant
Prior art date
Application number
PE2017000033A
Other languages
Spanish (es)
Inventor
Armenta Maria Elena Garcia
Ochoa Victor Guillermo Alvarez
Original Assignee
Representaciones E Investig Medicas S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53938368&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20171140(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Representaciones E Investig Medicas S A De C V filed Critical Representaciones E Investig Medicas S A De C V
Publication of PE20171140A1 publication Critical patent/PE20171140A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion se refiere a una novedosa combinacion farmaceutica sinergica de un agente antihiperalgesico, antialodinico, analogo del acido gama-aminobutirico (GABA) y un agente antiinflamatorio, en donde el agente antihiperalgesico, antialodinico es Pregabalina, y el agente antiinflamatorio es Meloxicam. La presente invencion ademas esta dirigida a composiciones farmaceuticas que comprenden dicha combinacion. Dichas composiciones son utiles para la prevencion y/o tratamiento del dolor neuropatico ocasionado por diversas etiologiasThe present invention relates to a novel synergistic pharmaceutical combination of an antihyperalgesic, anti-allodynic, gamma-aminobutyric acid (GABA) analogue and an anti-inflammatory agent, wherein the antihyperalgesic, anti-allodynamic agent is Pregabalin, and the anti-inflammatory agent is Meloxicam. The present invention is further directed to pharmaceutical compositions comprising such a combination. Said compositions are useful for the prevention and / or treatment of neuropathic pain caused by various etiologies.

PE2017000033A 2014-07-07 2015-07-07 ANTI HYPERALGESIC, ANTIALODINIC AND ANT-INFLAMMATORY PHARMACOLOGICAL COMBINATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT, AND ITS USE FOR THE TREATMENT OF NEUROPATHIC PAIN PE20171140A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2014008336A MX2014008336A (en) 2014-07-07 2014-07-07 Antihyperalgesic, antiallodynic and anti-inflammatory pharmacological combination, pharmaceutical compositions containing same and use thereof for treating neuropatic pain.

Publications (1)

Publication Number Publication Date
PE20171140A1 true PE20171140A1 (en) 2017-08-09

Family

ID=53938368

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2017000033A PE20171140A1 (en) 2014-07-07 2015-07-07 ANTI HYPERALGESIC, ANTIALODINIC AND ANT-INFLAMMATORY PHARMACOLOGICAL COMBINATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT, AND ITS USE FOR THE TREATMENT OF NEUROPATHIC PAIN

Country Status (5)

Country Link
BR (1) BR112017000359A2 (en)
CO (1) CO2017001076A2 (en)
MX (1) MX2014008336A (en)
PE (1) PE20171140A1 (en)
WO (1) WO2016005897A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3687520A4 (en) * 2017-09-28 2021-06-23 Nevakar, Inc Fixed dose combination formulations for treating pain
MX2019008467A (en) * 2019-07-16 2019-11-07 Federico Amezcua Amezcua A synergistic combination of s-ketorolaco and pregabalin in a pharmaceutical composition for the treatment of neuropathic pain.
CN112353767A (en) * 2020-11-16 2021-02-12 海南锦瑞制药有限公司 Diltiazem hydrochloride and pregabalin composition, and preparation method and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6129907A (en) 1999-08-04 2000-10-10 Colgate Palmolive Company Stable hydrogenated lupulone antibacterial oral compositions
JP4428053B2 (en) 2002-02-05 2010-03-10 味の素株式会社 Pharmaceutical composition containing gabapentin or pregabalin and N-type calcium channel antagonist
DE10331305A1 (en) 2003-07-10 2005-02-17 Siemens Ag Communication system, peer-to-peer message filtering computer and method for processing a peer-to-peer message
WO2006123247A2 (en) 2005-05-20 2006-11-23 Pfizer Limited Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands
JP5452494B2 (en) 2007-10-09 2014-03-26 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング A pharmaceutical composition for the treatment of neuropathic pain conditions comprising benfotiamine and one or more pharmaceutically active agents
DK2596784T3 (en) 2007-11-23 2017-03-06 Gruenenthal Gmbh Tapentadol compositions
MX336979B (en) 2011-12-16 2016-02-09 Senosiain S A De C V Lab Antineuritic pharmaceutical combination and compositions.

Also Published As

Publication number Publication date
WO2016005897A1 (en) 2016-01-14
BR112017000359A2 (en) 2018-06-26
MX2014008336A (en) 2016-01-07
CO2017001076A2 (en) 2017-05-31

Similar Documents

Publication Publication Date Title
CL2020002032A1 (en) Crystal of a compound derived from 7,8-difluoro-6,11-dihydrodibenzothiepine, pharmaceutical composition, useful in reducing the relief time of influenza symptoms to treat and / or prevent an infection caused by the influenza virus. (divisional application 201900325).
CL2023000767A1 (en) Methods to reduce the risk of cardiovascular events in a subject.
CL2018003588A1 (en) Use of myostatin inhibitors and combination therapies.
CL2017003138A1 (en) Tricyclic derivative compound, method of preparation thereof and pharmaceutical composition comprising it.
SV2017005461A (en) BENZAMIDS REPLACED WITH 1,3-TIAZOL-2-ILO
NI201600051A (en) COMBINATIONS OF HISTONE DESACETILASE INHIBITORS AND IMMUNOMODULATING DRUGS
EA201692437A1 (en) COMBINATION
GT201700132A (en) ISOXAZOLE HYDROXAMIC ACID COMPOUNDS AS INHIBITORS OF LPXC
DOP2016000253A (en) NEW COMPOUNDS
EA201792496A1 (en) METHODS OF TREATMENT OF INFLAMMATION OR NEUROPATHIC PAIN
BR112022008294A2 (en) PRODrug COMPOSITIONS AND TREATMENT METHODS
BR112018005905A2 (en) ? compound, pharmaceutical composition, methods to prevent or treat a disease or condition, organ damage, hepatotoxicity and fatty liver, and, use of a compound?
CL2019002218A1 (en) Triple combination formulations and methods to treat or reduce the risk of cardiovascular disease.
BR112017003745A2 (en) alpha-amino-beta-carboximuconic acid semialdehyde decarboxylase inhibitors
MX2022001796A (en) Methods and compositions to inhibit symptoms associated with veisalgia.
CL2019001746A1 (en) Aromatic carboxylic acid amides
BR112016024235A2 (en) pharmaceutical compositions comprising antibacterial agents
ECSP20023626A (en) NOVELTY DERIVATIVES OF PIRAZOLO-PIRROLO-PYRIMIDINE AS INHIBITORS OF P2X3
PE20171140A1 (en) ANTI HYPERALGESIC, ANTIALODINIC AND ANT-INFLAMMATORY PHARMACOLOGICAL COMBINATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT, AND ITS USE FOR THE TREATMENT OF NEUROPATHIC PAIN
DOP2016000251A (en) WNT SIGNALING ROAD INHIBITORS
EA201691792A1 (en) PHARMACEUTICAL COMPOSITIONS BASED ON VILDAGLIPTINA
UY36801A (en) PROCEDURE FOR THE TREATMENT OR PREVENTION OF IMMUNE CONDITIONS RELATED TO INFECTIONS USING A COMPOSITION THAT INCLUDES IgM
ECSP15050273A (en) ORAL FORMULATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
BR112019017314A2 (en) pharmaceutical compositions for combination therapy
BR112019025352A8 (en) CANCER-ASSOCIATED IMMUNOSUPPRESSION INHIBITORS